Figure 2.
Effect of allocation to casirivimab and imdevimab on 28-day mortality in (A) seronegative patients versus seropositive patients and (B) all participants overall
RR=rate ratio.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.